Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.

Bayer share price down 1% after $80 million cancer lawsuit loss

The herbicide maker's stock is down after a jury awards $80 million to a man claiming Roundup caused his cancer.

Bayer AG share price is down by 1% after losing an $80 million lawsuit brought by a man that claimed that its Roundup weed killer caused him to contract cancer. This lawsuit is one of thousands that the corporation faces since purchasing Roundup maker Monsanto.

Why did Bayer lose an $80 million lawsuit?

Edwin Hardeman filed a lawsuit against Bayer and Monsanto after claiming that using the product for decades on his property caused him to contract cancer. He and his lawyers maintain that the glysophate herbicide in Roundup came into contact with his skin and led him to develop stage 3 non-Hodgkins’s lymphoma. A jury found Bayer and Monsanto liable and awarded Hardeman $80 million in damages. In August, another man won $79 million in damages against the company. Jennifer Moore, one of Hardeman’s lawyers, criticised Monsanto after the verdict.

‘Today, the jury sent a message loud and clear that companies should no longer put products on the market for anyone to buy without being truthful, without testing their product and without warning if it causes cancer,’ said Moore.

Bayer’s response to the Roundup lawsuit loss

Bayer denied that Roundup causes cancer and expressed disappointment with the verdict. The corporation also said they will appeal the decision.

‘We are disappointed with the jury's decision, but this verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic. The verdict in this trial has no impact on future cases and trials, as each one has its own factual and legal circumstances,’ said Bayer in a statement.

There is conflicting evidence about whether Roundup causes cancer or not. France’s International Agency for Research on Cancer called Roundup a ‘probable human carcinogen.’ However, the US Environmental Protection Agency (EPA) said the herbicide is safe to use.

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.